documents: FDA-2026-D-1255-0001
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2026-D-1255-0001 | FDA | FDA-2026-D-1255 | Safety Assessment of Genome Editing in Human Gene Therapy Products Using Next-Generation Sequencing; Draft Guidance for Industry; Availability | Notice | Notice of Availability | 2026-04-15T04:00:00Z | 2026 | 4 | 2026-04-15T04:00:00Z | 2026-04-15T17:11:56Z | 2026-07285 | 0 | 0 | 09000064b92810b1 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref